ArticleScientific reports2025
Incorporating PET-MIL-101(Fe) within cellulose acetate membrane for thin film microextraction of neonicotinoid insecticides in water.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Herein, cellulose acetate membrane modified with polyethylene terephthalate derived MIL-101(Fe) (PET-MIL-101(Fe)) was used as an extraction phase for the direct immersion-thin film microextraction method (DI-TFME) of neonicotinoid insecticides in water samples. The quantitative analysis of clothianidin, imidacloprid, thiacloprid and thiamethoxam was carried out using high-pressure liquid chromatography (HPLC-DAD). The morphological and structural characteristics of the materials were studied using transmission electron microscopy (TEM), X-ray diffraction analysis (XRD), and energy dispersive X-ray spectrometry (EDX). Under optimum conditions, acceptable analytical performance for the developed DI-TFME/HPLC-DAD method was attained. The linearity of the method ranged from 0.04 to 500 µg/L with R
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.